ClinConnect ClinConnect Logo
Search / Trial NCT03501797

Choir Singing in Aphasia Rehabilitation

Launched by UNIVERSITY OF HELSINKI · Apr 10, 2018

Trial Information

Current as of May 29, 2025

Completed

Keywords

ClinConnect Summary

BACKGROUND: Singing is a highly stimulating and versatile activity for the brain, combining vocal-motor, auditory, linguistic, cognitive, emotional, and social brain processes, both in the left and right hemisphere. The capacity to sing is often preserved in aphasia after stroke, and singing-based methods, such as Melodic Intonation Therapy (MIT), can be effective in rehabilitating speech production in aphasics. Also emotionally and socially, singing could provide a powerful alternative channel for aphasic patients to express their emotions and interact with others, but the communal or grou...

Gender

ALL

Eligibility criteria

  • The following inclusion criteria are used in patient recruiment:
  • 1. age over 18
  • 2. Finnish-speaking
  • 3. time since stroke \> 6 months
  • 4. at least minor non-fluent aphasia due to stroke (BDAE Aphasia Severity Rating scale score ≤ 4)
  • 5. no hearing deficit
  • 6. no severe cognitive impairment affecting comprehension (the patient is able to understand the purpose of the study and give an informed consent)
  • 7. no neurological / psychiatric co-morbidity or substance abuse
  • 8. ability to produce vocal sound (through singing or humming).

About University Of Helsinki

The University of Helsinki, a prestigious institution in Finland, is dedicated to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge studies that aim to improve patient outcomes and contribute to the global knowledge base in medicine. Its commitment to ethical standards and rigorous methodology ensures the integrity and reliability of its clinical research initiatives, making it a key player in the development of novel therapeutic strategies and healthcare solutions.

Locations

Helsinki, , Finland

Helsinki, , Finland

Patients applied

0 patients applied

Trial Officials

Teppo Särkämö, PhD

Principal Investigator

University of Helsinki

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials